| Dr Justin James Dillingham, DO | |
|
3126 S Jackson Ave, Ste 101, Joplin, MO 64804-2534 | |
| (417) 208-3465 | |
| Not Available |
| Full Name | Dr Justin James Dillingham |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 3126 S Jackson Ave, Joplin, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003103490 | NPI | - | NPPES |
| 1003103490 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2014010517 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Freeman Neosho Hospital | Neosho, MO | Hospital |
| Freeman Health System - Freeman West | Joplin, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Freeman Neosho Hospital | 4284624552 | 33 |
| Freeman-oak Hill Health System | 8325942253 | 316 |
News Archive
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form-which tests positive for hormone receptors (HR+) and negative for the HER2 receptor-usually respond well to treatment.
In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.
BioCen Natural Products Development Group President Daniel J. Kennedy today commented, "We are pleased to announce that the development of BNPD's first commercial health drink, Vitamin "X" is near completion." For the past 8 weeks, BNPD has been performing test market analysis to determine the best flavor(s) and percentage of Astaxanthin actives for each bottle.
The goal of an "AIDS-free generation" "requires an ambitious implementation-science agenda that improves efficiency and effectiveness and incorporates strategies for overcoming the stigma and discrimination that continue to limit the uptake and utilization of treatment, prevention and care services," AIDS 2012 Co-Chair Diane Havlir of the University of California-San Francisco School of Medicine and Chris Beyrer of the Johns Hopkins Center for AIDS Research write in a New England Journal of Medicine opinion piece.
› Verified 4 days ago
| Entity Name | Freeman-oak Hill Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679517023 PECOS PAC ID: 8325942253 Enrollment ID: O20040218000570 |
News Archive
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form-which tests positive for hormone receptors (HR+) and negative for the HER2 receptor-usually respond well to treatment.
In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.
BioCen Natural Products Development Group President Daniel J. Kennedy today commented, "We are pleased to announce that the development of BNPD's first commercial health drink, Vitamin "X" is near completion." For the past 8 weeks, BNPD has been performing test market analysis to determine the best flavor(s) and percentage of Astaxanthin actives for each bottle.
The goal of an "AIDS-free generation" "requires an ambitious implementation-science agenda that improves efficiency and effectiveness and incorporates strategies for overcoming the stigma and discrimination that continue to limit the uptake and utilization of treatment, prevention and care services," AIDS 2012 Co-Chair Diane Havlir of the University of California-San Francisco School of Medicine and Chris Beyrer of the Johns Hopkins Center for AIDS Research write in a New England Journal of Medicine opinion piece.
› Verified 4 days ago
| Entity Name | Freeman Neosho Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083045686 PECOS PAC ID: 4284624552 Enrollment ID: O20040729000101 |
News Archive
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form-which tests positive for hormone receptors (HR+) and negative for the HER2 receptor-usually respond well to treatment.
In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.
BioCen Natural Products Development Group President Daniel J. Kennedy today commented, "We are pleased to announce that the development of BNPD's first commercial health drink, Vitamin "X" is near completion." For the past 8 weeks, BNPD has been performing test market analysis to determine the best flavor(s) and percentage of Astaxanthin actives for each bottle.
The goal of an "AIDS-free generation" "requires an ambitious implementation-science agenda that improves efficiency and effectiveness and incorporates strategies for overcoming the stigma and discrimination that continue to limit the uptake and utilization of treatment, prevention and care services," AIDS 2012 Co-Chair Diane Havlir of the University of California-San Francisco School of Medicine and Chris Beyrer of the Johns Hopkins Center for AIDS Research write in a New England Journal of Medicine opinion piece.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin James Dillingham, DO 3126 S Jackson Ave, Ste 101, Joplin, MO 64804-2534 Ph: (417) 208-3465 | Dr Justin James Dillingham, DO 3126 S Jackson Ave, Ste 101, Joplin, MO 64804-2534 Ph: (417) 208-3465 |
News Archive
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form-which tests positive for hormone receptors (HR+) and negative for the HER2 receptor-usually respond well to treatment.
In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.
BioCen Natural Products Development Group President Daniel J. Kennedy today commented, "We are pleased to announce that the development of BNPD's first commercial health drink, Vitamin "X" is near completion." For the past 8 weeks, BNPD has been performing test market analysis to determine the best flavor(s) and percentage of Astaxanthin actives for each bottle.
The goal of an "AIDS-free generation" "requires an ambitious implementation-science agenda that improves efficiency and effectiveness and incorporates strategies for overcoming the stigma and discrimination that continue to limit the uptake and utilization of treatment, prevention and care services," AIDS 2012 Co-Chair Diane Havlir of the University of California-San Francisco School of Medicine and Chris Beyrer of the Johns Hopkins Center for AIDS Research write in a New England Journal of Medicine opinion piece.
› Verified 4 days ago
Michael D David, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1130 E 32nd St, Joplin, MO 64804 Phone: 417-347-2273 Fax: 417-347-2277 | |
Dr. Stephen Ray Thomas, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3202 Mcintosh Cir, Ste 302, Joplin, MO 64804 Phone: 417-347-8525 Fax: 417-347-8536 | |
Dennis Younker, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 702 E 34th St Ste 202, Joplin, MO 64804 Phone: 417-347-2535 Fax: 417-347-2553 | |
Dr. Maria Fe Fiel Bruce, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3126 S Jackson Ave, Suite 201, Joplin, MO 64804 Phone: 417-781-4727 Fax: 417-627-8727 | |
Shuruk Haib, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 2216 E 32nd St Ste 101, Joplin, MO 64804 Phone: 417-556-2780 Fax: 417-556-2781 | |
Dr. Noureddine El Moghrabi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Mercy Way, Joplin, MO 64804 Phone: 417-781-2727 |